By Investors Hub
European stocks are moving lower on Friday as investors remain concerned about weakening global growth after the European Central Bank slashed its forecasts and China reported worse than expected trade data for the month of February.
While the U.K.?s FTSE 100 Index has tumbled by 1.1 percent, the French CAC 40 Index and the German DAX Index are both down by 0.8 percent.
Swiss drug major Roche Holding has edged down slightly. The company announced that it has received approval from the European Commission for Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer.
British retailing group Sports Direct International has also dropped. The company has demanded the removal of all of the board of Debenhams except one, and the appointment of Mike Ashley to an executive role. Shares of Debenhams have soared.
Serco Group has also fallen despite the company signing a new contract to provide field office support services to the U.S. Pension Benefit Guaranty Corp.
Bayer has also dropped in Frankfurt after announcing it has submitted a marketing authorization application to the European Medicines Agency for darolutamide for the treatment of patients with non-metastatic castration-resistant prostate cancer.
Adedapo Adesanya